Pacira BioSciences Appoints New CEO, David Stack
Ticker: PCRX · Form: 8-K · Filed: Jan 30, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Jan 30, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, ceo-appointment, board-of-directors
Related Tickers: PCRX
TL;DR
Pacira BioSciences just named David Stack the new CEO, bringing back a familiar face to lead the charge.
AI Summary
Pacira BioSciences, Inc. announced on January 28, 2025, the appointment of Dr. David M. Stack as Chief Executive Officer, effective immediately. Dr. Stack, who previously served as CEO of Pacira Pharmaceuticals, Inc. and has been a board member since 2011, will also join the Board of Directors. He succeeds Hubert L. "Skip" McKee, who will transition to the role of Chairman of the Board.
Why It Matters
The appointment of a new CEO, especially one with prior leadership experience at the company, can signal a strategic shift or a renewed focus on growth and operational efficiency.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- Dr. David M. Stack (person) — Appointed CEO
- Hubert L. "Skip" McKee (person) — Outgoing CEO, transitioning to Chairman
- Pacira Pharmaceuticals, Inc. (company) — Previous company of Dr. Stack
- January 28, 2025 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Executive Officer of Pacira BioSciences, Inc.?
Dr. David M. Stack has been appointed as the new Chief Executive Officer of Pacira BioSciences, Inc., effective January 28, 2025.
What is the effective date of Dr. David M. Stack's appointment as CEO?
The appointment of Dr. David M. Stack as CEO is effective immediately as of January 28, 2025.
What previous role did Dr. David M. Stack hold at Pacira?
Dr. David M. Stack previously served as the CEO of Pacira Pharmaceuticals, Inc. and has been a member of the Board of Directors since 2011.
Who is Dr. David M. Stack succeeding as CEO?
Dr. David M. Stack is succeeding Hubert L. "Skip" McKee as CEO.
What new role will Hubert L. "Skip" McKee assume?
Hubert L. "Skip" McKee will transition to the role of Chairman of the Board.
Filing Stats: 1,189 words · 5 min read · ~4 pages · Grade level 13.5 · Accepted 2025-01-30 08:01:38
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share PCRX Nasdaq Global Select Mar
Filing Documents
- pcrx-20250128.htm (8-K) — 43KB
- pcrx-991jan2025.htm (EX-99.1) — 18KB
- paciralogo2025.jpg (GRAPHIC) — 80KB
- 0001396814-25-000022.txt ( ) — 303KB
- pcrx-20250128.xsd (EX-101.SCH) — 2KB
- pcrx-20250128_lab.xml (EX-101.LAB) — 22KB
- pcrx-20250128_pre.xml (EX-101.PRE) — 13KB
- pcrx-20250128_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On January 30, 2025, the Company issued a press release announcing the Board changes. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated January 30, 2025 . 104 Cover Page Interactive Data File (Formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PACIRA BIOSCIENCES, INC. (REGISTRANT) Dated: January 30, 2025 By: /s/ KRISTEN WILLIAMS Kristen Williams Chief Administrative Officer and Secretary